title: Chancroid in El Salvador. Increasing incidence, clinical features, and therapeutics.
abstract: Ninety-five cases of chancroid were studied during a 6-month period in a dermatologic service in San Salvador; 88 (92.6%) were men and 7 (7.4%) were women, with a ratio of 12.5:1. The minimum age was 13 years and the maximum 46, with an average of 21 years. In most of the cases (81.05%), the incubation period varied from 1 to 7 days. Very painful adenopathies, enough to make walking difficult, were a striking feature in 69 cases (72.6%). Treatment was curative in all cases, except two, who received treatment with co-trifamole (sulfatrifamole 400 mg/trimethoprim 80 mg). In two cases in which it was not possible to use co-moxole (allergy, pregnancy), treatment was also curative using erythromycin.
authors.affiliation: Department of Dermatology, University of El Salvador, San Salvador.
authors.forename: O
authors.initials: O
authors.lastname: Orellana-Díaz
authors.forename: E
authors.initials: E
authors.lastname: Hernández-Pérez
mesh_terms: D000293:Adolescent; D000328:Adult; D002602:Chancroid / Q000188:drug therapy / Q000453:epidemiology* / Q000473:pathology; D004338:Drug Combinations / Q000627:therapeutic use; D004544:El Salvador; D005260:Female; D006119:Groin; D006801:Humans; D008199:Lymphadenitis / Q000473:pathology; D008297:Male; D008875:Middle Aged; D013423:Sulfamoxole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D014456:Ulcer / Q000473:pathology
chemical_list: D004338:Drug Combinations; C013268:sulfamoxole, trimethoprim drug combination; D014295:Trimethoprim; D013423:Sulfamoxole